Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam

Published 13/12/2023, 04:22
© Reuters Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
ARKG
-
ARKK
-
ARKW
-
CRSP
-
ARKF
-
ADPT
-
TXG
-
COIN
-
TOST
-

Benzinga - Cathie Wood-led Ark Invest made a notable move in the market by selling a significant portion of its Coinbase Global Inc (NASDAQ:COIN) shares on Tuesday. This decision comes as cryptocurrencies, including Bitcoin, experience a downturn, prompting a strategic shift in Ark Invest’s portfolio.

The Coinbase Trade

On Tuesday, Ark sold a total of 82,255 Coinbase shares worth $11.48 million through ARK Innovation ETF (NYSE:ARKK), ARK Next Generation Internet ETF (NYSE:ARKW) and Ark Fintech Innovation ETF (NYSE:ARKF). On the day Coinbase shares closed 1.2% higher at $139.62.

Ark Invest’s decision to reduce its holdings in Coinbase is particularly significant given the recent market trends. According to Benzinga’s coverage, Coinbase co-founder Fred Ehrsam and Ark Invest collectively offloaded over $14 million in COIN shares over 48 hours leading up to Tuesday. Until that time Ark had reported a sale of $100 million worth of COIN shares in December.

Ark’s moves seemingly align with the broader market sentiment where cryptocurrencies are facing a phase of uncertainty. Ark’s sale of Coinbase shares is part of a larger trend of divesting from crypto-related assets, as seen in their recent sale of Grayscale Bitcoin Trust shares.

Other Key Trades:

  • Ark Invest bought 91,635 shares of Toast Inc (NYSE:TOST) through ARKF and 112,742 shares through ARKW, indicating a growing interest in this technology-driven company.
  • The firm also increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP) by purchasing 12,108 shares, reflecting confidence in the biotech sector through ARK Genomic Revolution ETF (NYSE:ARKG) and 52,287 shares through ARKK.
  • Significant investments were made in Adaptive Biotechnologies (NASDAQ:ADPT), with 146,414 shares added via ARKG, showcasing Ark’s focus on innovative medical technologies.
  • Another notable buy was in 10X Genomics Inc (NASDAQ:TXG), with 5,914 shares acquired through ARKG and a further 3,892 shares through ARKK, further diversifying Ark’s portfolio in the biotech space.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See Also: Cathie Wood Predicts Bitcoin Could Rise To $1.5M

Ark Invest’s recent trades, especially the sale of Coinbase shares, highlight the fund’s adaptive strategy in response to the dynamic crypto market. As the investment landscape continues to evolve, Ark’s moves offer valuable insights into emerging market trends and investor sentiment.

Read Next: Exclusive: Ark Invest’s Early Belief In Nvidia And Tesla

Engineered by Benzinga Neuro, Edited by

Shivdeep Dhaliwal

The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.

Learn more.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.